5-hydroxytryptamine (serotonin) receptor 3B, also known as HTR3B, is a human gene. The protein encoded by this gene is a subunit of the 5-HT3 receptor.[1][2]
References
↑Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (January 1999). "The 5-HT3B subunit is a major determinant of serotonin-receptor function". Nature. 397 (6717): 359–63. doi:10.1038/16941. PMID9950429.
Meineke C, Tzvetkov MV, Bokelmann K, et al. (2008). "Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene". Pharmacogenet. Genomics. 18 (3): 219–30. doi:10.1097/FPC.0b013e3282f51092. PMID18300944.
Kato M, Fukuda T, Wakeno M, et al. (2006). "Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients". Neuropsychobiology. 53 (4): 186–95. doi:10.1159/000094727. PMID16874005.
Hu XQ, Peoples RW (2008). "The 5-HT3B subunit confers spontaneous channel opening and altered ligand properties of the 5-HT3 receptor". J. Biol. Chem. 283 (11): 6826–31. doi:10.1074/jbc.M707571200. PMID18187416.
Ji X, Takahashi N, Branko A, et al. (2008). "An association between serotonin receptor 3B gene (HTR3B) and treatment-resistant schizophrenia (TRS) in a Japanese population". Nagoya journal of medical science. 70 (1–2): 11–7. PMID18807291.
Kato M, Serretti A (2008). "Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder". Mol. Psychiatry. 15 (5): 473–500. doi:10.1038/mp.2008.116. PMID18982004.
Walstab J, Hammer C, Bönisch H, et al. (2008). "Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors". Pharmacogenet. Genomics. 18 (9): 793–802. doi:10.1097/FPC.0b013e3283050117. PMID18698232.
Yosifova A, Mushiroda T, Stoianov D, et al. (2009). "Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population". Journal of Affective Disorders. 117 (1–2): 87–97. doi:10.1016/j.jad.2008.12.021. PMID19328558.
Tzvetkov MV, Meineke C, Oetjen E, et al. (2007). "Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine". Gene. 386 (1–2): 52–62. doi:10.1016/j.gene.2006.08.002. PMID17010535.
Fasching PA, Kollmannsberger B, Strissel PL, et al. (2008). "Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy". J. Cancer Res. Clin. Oncol. 134 (10): 1079–86. doi:10.1007/s00432-008-0387-1. PMID18389280.
Tanaka M, Kobayashi D, Murakami Y, et al. (2008). "Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea". Int. J. Neuropsychopharmacol. 11 (2): 261–7. doi:10.1017/S1461145707007985. PMID17697394.
Gratacòs M, Costas J, de Cid R, et al. (2009). "Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment". Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (6): 808–16. doi:10.1002/ajmg.b.30902. PMID19086053.
Krzywkowski K, Davies PA, Irving AJ, et al. (2008). "Characterization of the effects of four HTR3B polymorphisms on human 5-HT3AB receptor expression and signalling". Pharmacogenet. Genomics. 18 (12): 1027–40. doi:10.1097/FPC.0b013e328310f950. PMID19008750.
Smith AK, Dimulescu I, Falkenberg VR, et al. (2008). "Genetic evaluation of the serotonergic system in chronic fatigue syndrome". Psychoneuroendocrinology. 33 (2): 188–97. doi:10.1016/j.psyneuen.2007.11.001. PMID18079067.
de Krom M, Staal WG, Ophoff RA, et al. (2009). "A common variant in DRD3 receptor is associated with autism spectrum disorder". Biol. Psychiatry. 65 (7): 625–30. doi:10.1016/j.biopsych.2008.09.035. PMID19058789.
